FDA Approves Oral Ferric Maltol for Iron Deficiency in Adults |
Clinical News
eMediNexus Coverage from: 
FDA Approves Oral Ferric Maltol for Iron Deficiency in Adults

2 Read Comments                

The US Food and Drug Administration (FDA) has approved oral ferric maltol (Accrufer, Shield Therapeutics) for the treatment of iron deficiency in adults.

The product is already approved in the European Union and Switzerland for the treatment of iron deficiency in adults, where it is sold as Feraccru.

Ferric maltol, a nonsalt formulation of ferric iron, provides an alternative to salt-based oral iron therapies, with fewer of the gastrointestinal side effects typically observed with salt-based therapies, the company said... (Medscape)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now